MicroRNAs and breast cancer malignancy: An overview of miRNA-regulated cancer processes leading to metastasis

Cancer Biomarkers

Volumn 11, Issue 6, 2012, Pages 269-280

  Harquail, Jason ^a,b   Benzina, Sami ^a,b   Robichaud, Gilles A ^a,b  

^a UNIVERSITÉ DE MONCTON   (Canada)

^b ATLANTIC CANCER RESEARCH INSTITUTE   (Canada)

Author keywords

angiogenesis; breast cancer; EMT; invasion; MET; metastasis; migration; miRNA

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 125B; MICRORNA 126; MICRORNA 137; MICRORNA 193B; MICRORNA 194; MICRORNA 200; MICRORNA 203; MICRORNA 21; MICRORNA 218; MICRORNA 224; MICRORNA 31; MICRORNA 335; MICRORNA 34A; MICRORNA 373; MICRORNA 519C; MICRORNA 520C; MICRORNA 632; MICRORNA 7; MICRORNA 9; UNCLASSIFIED DRUG;

ANGIOGENESIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 84871549520     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-120291     Document Type: Review

References (113)

1. L. Adam, M. Zhong, W. Choi, W. Qi, M. Nicoloso, A. Arora, G. Calin, H. Wang, A. Siefker-Radtke, D. McConkey, M. Bar-Eli and C. Dinney, miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy, Clin Cancer Res 15 (2009), 5060-5072.
2. F. Ahmed, M. Kumar and G. P. Raghava, Prediction of polyadenylation signals in human DNA sequences using nucleotide frequencies, In Silico Biol 9 (2009), 135-148.
3. M. A. S. Anne J. Ridley, Keith Burridge, Richard A. Firtel, Mark H. Ginsberg, Gary Borisy, J. Thomas Parsons and Alan RickHorwitz, CellMigration: Integrating Signals from Front to Back, Science 302 (2003), 1704-1709. (Pubitemid 37505725)
4. I.A. Asangani, S. A. Rasheed, D. A.Nikolova, J. H. Leupold, N. H. Colburn, S. Post and H. Allgayer, MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer, Oncogene 27 (2008), 2128-2136. (Pubitemid 351485639)
5. M. J. Barbera, I. Puig, D. Dominguez, S. Julien-Grille, S. Guaita-Esteruelas, S. Peiro, J. Baulida, C. Franci, S. Dedhar, L. Larue and A. Garcia de Herreros, Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells, Oncogene 23 (2004), 7345-7354. (Pubitemid 39382137)
6. D. P. Bartel, MicroRNAs: Target recognition and regulatory functions, Cell 136 (2009), 215-233.
7. B. Baum, J. Settleman and M. P. Quinlan, Transitions between epithelial and mesenchymal states in development and disease, Semin Cell Dev Biol 19 (2008), 294-308.
8. M. Bloomston, W. L. Frankel, F. Petrocca, S. Volinia, H. Alder, J. P. Hagan, C. G. Liu, D. Bhatt, C. Taccioli and C.M. Croce, MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis, JAMA 297 (2007), 1901-1908. (Pubitemid 46707844)
9. C. L. Bockmeyer, M. Christgen, M. Muller, S. Fischer, P. Ahrens, F. Langer, H. Kreipe and U. Lehmann, MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes, Breast Cancer Res Treat 130 (2011), 735-745.
10. M. Bousquet, C. Quelen, R. Rosati, V. Mansat-De Mas, R. La Starza, C. Bastard, E. Lippert, P. Talmant, M. Lafage-Pochitaloff, D. Leroux, C. Gervais, F. Viguie, J. L. Lai, C. Terre, B. Beverlo, C. Sambani, A. Hagemeijer, P. Marynen, G. Delsol, N. Dastugue, C. Mecucci and P. Brousset, Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation, J Exp Med 205 (2008), 2499-2506.
11. S. Brabletz and T. Brabletz, The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer?, EMBO Rep 11 (2010), 670-677.
12. C. E. Brinckerhoff and L. M. Matrisian, Matrix metalloproteinases: A tail of a frog that became a prince, Nat Rev Mol Cell Biol 3 (2002), 207-214.
13. G. A. Calin, C. G. Liu, C. Sevignani, M. Ferracin, N. Felli, C. D. Dumitru, M. Shimizu, A. Cimmino, S. Zupo, M. Dono, M. L.Dell'Aquila, H. Alder, L. Rassenti, T. J. Kipps, F. Bullrich, M. Negrini and C. M. Croce, MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias, Proc Natl Acad Sci USA 101 (2004), 11755-11760. (Pubitemid 39095368)
14. S. T. Cha, P. S. Chen, G. Johansson, C. Y. Chu, M. Y. Wang, Y. M. Jeng, S. L. Yu, J. S. Chen, K. J. Chang, S. H. Jee, C. T. Tan, M. T. Lin and M. L. Kuo, MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis, Cancer Res 70 (2010), 2675-2685.
15. N. R. Choudhury and G. Michlewski, Terminal loopmediated control of microRNA biogenesis, Biochem Soc Trans 40 (2012), 789-793.
16. H. L. Chua, P. Bhat-Nakshatri, S. E. Clare, A. Morimiya, S. Badve and H. Nakshatri, NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2, Oncogene 26 (2007), 711-724. (Pubitemid 46204250)
17. S. Davis, T. H. Aldrich, P. F. Jones, A. Acheson, D. L. Compton, V. Jain, T. E. Ryan, J. Bruno, C. Radziejewski, P. C. Maisonpierre and G. D. Yancopoulos, Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretiontrap expression cloning, Cell 87 (1996), 1161-1169. (Pubitemid 27010100)
18. C. E. De Bock, Z. Lin, A. H. Mekkawy, J. A. Byrne and Y. Wang, Interaction between urokinase receptor and heat shock protein MRJ enhances cell adhesion, Int J Oncol 36 (2010), 1155-1163.
19. C. Delaloy, L. Liu, J. A. Lee, H. Su, F. Shen, G.Y.Yang,W. L. Young, K. N. Ivey and F. B. Gao, MicroRNA-9 coordinates proliferation and migration of human embryonic stem cellderived neural progenitors, Cell Stem Cell 6 (2010), 323-335.
20. D. M. Dykxhoorn, Y. Wu, H. Xie, F. Yu, A. Lal, F. Petrocca, D. Martinvalet, E. Song, B. Lim and J. Lieberman, miR-200 enhances mouse breast cancer cell colonization to form distant metastases, PLoS One 4 (2009), e7181.
21. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers and D. M. Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer 127 (2010), 2893-2917.
22. N. Ferrara and W. J. Henzel, Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells, Biochem Biophys Res Commun 161 (1989), 851-858. (Pubitemid 19162712)
23. W. Filipowicz, S.N. Bhattacharyya andN. Sonenberg, Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight?, Nat Rev Genet 9 (2008), 102-114.
24. J. E. Fish, M. M. Santoro, S. U. Morton, S. Yu, R. F. Yeh, J. D. Wythe, K. N. Ivey, B. G. Bruneau, D. Y. Stainier and D. Srivastava, miR-126 regulates angiogenic signaling and vascular integrity, Dev Cell 15 (2008), 272-284.
25. J. Folkman, Tumor angiogenesis: therapeutic implications, N Engl J Med 285 (1971), 1182-1186.
26. J. Folkman, E. Merler, C. Abernathy and G. Williams, Isolation of a tumor factor responsible for angiogenesis, J Exp Med 133 (1971), 275-288.
27. P. Friedl and S. Alexander, Cancer invasion and the microenvironment: Plasticity and reciprocity, Cell 147 (2011), 992-1009.
28. V. Fulci, T. Colombo, S. Chiaretti, M. Messina, F. Citarella, S. Tavolaro, A. Guarini, R. Foa and G. Macino, Characterization of B-and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles, Genes Chromosomes Cancer 48 (2009), 1069-1082.
29. R. Garzon, M. Garofalo, M. P. Martelli, R. Briesewitz, L. Wang, C. Fernandez-Cymering, S. Volinia, C. G. Liu, S. Schnittger, T. Haferlach, A. Liso, D. Diverio, M.Mancini, G. Meloni, R. Foa, M. F.Martelli, C.Mecucci, C.M. Croce and B. Falini, Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin, Proc Natl Acad Sci USA 105 (2008), 3945-3950. (Pubitemid 351723504)
30. A. Gaur, D. A. Jewell, Y. Liang, D. Ridzon, J. H. Moore, C. Chen, V. R. Ambros and M. A. Israel, Characterization of microRNAexpression levels and their biological correlates in human cancer cell lines, Cancer Res 67 (2007), 2456-2468. (Pubitemid 46548930)
31. S. Gilad, G. Lithwick-Yanai, I. Barshack, S. Benjamin, I. Krivitsky, T. B. Edmonston, M. Bibbo, C. Thurm, L. Horowitz, Y. Huang, M. Feinmesser, J. Steve Hou, B. St Cyr, I. Burnstein, H. Gibori, N. Dromi, M. Sanden, M. Kushnir and R. Aharonov, Classification of the Four Main Types of Lung Cancer Using a MicroRNA-Based Diagnostic Assay, J Mol Diagn 14 (2012), 510-517.
32. V. M. Golubovskaya, F. A. Kweh and W. G. Cance, Focal adhesion kinase and cancer, Histol Histopathol 24 (2009), 503-510.
33. P. A. Gregory, A. G. Bert, E. L. Paterson, S. C. Barry, A. Tsykin, G. Farshid, M. A. Vadas, Y. Khew-Goodall and G. J. Goodall, The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1, Nat Cell Biol 10 (2008), 593-601. (Pubitemid 351627379)
34. P. A. Gregory, C. P. Bracken, A. G. Bert and G. J. Goodall, MicroRNAs as regulators of epithelial-mesenchymal transition, Cell Cycle 7 (2008), 3112-3118.
35. Y. Guan, H. Yao, Z. Zheng, G. Qiu and K. Sun, MiR-125b targets BCL3 and suppresses ovarian cancer proliferation, Int J Cancer 128 (2011), 2274-2283.
36. A. Gupta, E. Caffrey, G. Callagy and S. Gupta, Oestrogendependent regulation of miRNA biogenesis: Many ways to skin the cat, Biochem Soc Trans 40 (2012), 752-758.
37. I. K. Guttilla, B. D. Adams and B. A. White, ERalpha, microRNAs, and the epithelial-mesenchymal transition in breast cancer, Trends Endocrinol Metab 23 (2012), 73-82.
38. M. Han, M. Liu, Y. Wang, X. Chen, J. Xu, Y. Sun, L. Zhao, H. Qu, Y. Fan and C. Wu, Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN, PLoS One 7 (2012), e39520.
39. M. Han, M. Liu, Y. Wang, Z. Mo, X. Bi, Z. Liu, Y. Fan, X. Chen and C. Wu, Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells, Mol Cell Biochem 363 (2012), 427-436.
40. S. T. Hashimi, J. A. Fulcher, M. H. Chang, L. Gov, S. Wang andB. Lee,MicroRNAprofiling identifiesmiR-34a andmiR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation, Blood 114 (2009), 404-414.
41. E. D. Hay, The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it, Dev Dyn 233 (2005), 706-720. (Pubitemid 40853448)
42. L. He, X. He, L. P. Lim, E. de Stanchina, Z. Xuan, Y. Liang, W. Xue, L. Zender, J. Magnus, D. Ridzon, A. L. Jackson, P. S. Linsley, C. Chen, S.W. Lowe,M. A. Cleary and G. J. Hannon, A microRNA component of the p53 tumour suppressor network, Nature 447 (2007), 1130-1134. (Pubitemid 47014436)
43. H. M. Heneghan, N. Miller, A. J. Lowery, K. J. Sweeney, J. Newell and M. J. Kerin, Circulating microRNAs as novel minimally invasive biomarkers for breast cancer, Ann Surg 251 (2010), 499-505.
44. M. Heroult, F. Schaffner and H. G. Augustin, Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression, Exp Cell Res 312 (2006), 642-650. (Pubitemid 43290340)
45. M. A. Hildebrandt, J. Gu, J. Lin, Y. Ye, W. Tan, P. Tamboli, C. G.Wood and X.Wu, Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma, Oncogene 29 (2010), 5724-5728.
46. E. N. Howe, D. R. Cochrane and J. K. Richer, The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity, J Mammary Gland Biol Neoplasia 17 (2012), 65-77.
47. X. Hu, D. M. Macdonald, P. C. Huettner, Z. Feng, I. M. El Naqa, J. K. Schwarz, D.G. Mutch, P. W. Grigsby, S. N. Powell and X. Wang, A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer, Gynecol Oncol 114 (2009), 457-464.
48. L. Huang, T. Dai, X. Lin, X. Zhao, X. Chen, C. Wang, X. Li, H. Shen and X. Wang, MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells, Biochem Biophys Res Commun 425 (2012), 127-133.
49. L. Huang, J. Luo, Q. Cai, Q. Pan, H. Zeng, Z. Guo,W. Dong, J. Huang and T. Lin, MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3, Int J Cancer 128 (2011), 1758-1769.
50. Q. Huang, K. Gumireddy, M. Schrier, C. le Sage, R. Nagel, S. Nair, D. A. Egan, A. Li, G. Huang, A. J. Klein-Szanto, P. A. Gimotty, D. Katsaros, G. Coukos, L. Zhang, E. Pure and R. Agami, The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis, Nat Cell Biol 10 (2008), 202-210. (Pubitemid 351194050)
51. H. Hugo, M. L. Ackland, T. Blick, M. G. Lawrence, J. A. Clements, E. D. Williams and E. W. Thompson, Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression, J Cell Physiol 213 (2007), 374-383. (Pubitemid 47509716)
52. S. A. Ibrahim, G. W. Yip, C. Stock, J. W. Pan, C. Neubauer, M. Poeter, D. Pupjalis, C. Y. Koo, R. Kelsch, R. Schule, U. Rescher, L. Kiesel and M. Gotte, Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase-and E-cadherin-dependent mechanism, Int J Cancer 131 (2012), E884-896.
53. M.V. Iorio, M. Ferracin, C. G. Liu, A.Veronese, R. Spizzo, S. Sabbioni, E.Magri, M. Pedriali, M. Fabbri, M. Campiglio, S. Menard, J. P. Palazzo, A. Rosenberg, P. Musiani, S. Volinia, I. Nenci, G. A. Calin, P. Querzoli, M. Negrini and C. M. Croce, MicroRNA gene expression deregulation in human breast cancer, Cancer Res 65 (2005), 7065-7070. (Pubitemid 41161233)
54. M. V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, P. Casalini, C. Taccioli, S. Volinia, C. G. Liu, H. Alder, G. A. Calin, S. Menard and C. M. Croce, MicroRNA signatures in human ovarian cancer, Cancer Res 67 (2007), 8699-8707. (Pubitemid 47437445)
55. M. Kalkatawi, F. Rangkuti, M. Schramm, B. R. Jankovic, A. Kamau, R. Chowdhary, J. A. Archer and V. B. Bajic, Dragon PolyA Spotter: Predictor of poly(A) motifs within human genomic DNA sequences, Bioinformatics 28 (2012), 127-129.
56. D. Kong, Y. Li, Z. Wang and F. H. Sarkar, Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins? Cancers 3 (2011), 716-729.
57. M.Korpal, E. S. Lee, G. HuandY.Kang, ThemiR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2, J Biol Chem283 (2008), 14910-14914.
58. B. Kumar, A. Yadav, J. Lang, T. N. Teknos and P. Kumar, Dysregulation ofmicroRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis, PLoS One 7 (2012), e37601.
59. X. F. Le, M. I. Almeida, W. Mao, R. Spizzo, S. Rossi, M. S. Nicoloso, S. Zhang, Y. Wu, G. A. Calin and R. C. Bast, Jr., Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer, PLoS One 7 (2012), e41170.
60. R. C. Lee, R. L. Feinbaum and V. Ambros, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell 75 (1993), 843-854. (Pubitemid 24014542)
61. M. Legendre, W. Ritchie, F. Lopez and D. Gautheret, Differential repression of alternative transcripts: A screen for miRNA targets, PLoS Comput Biol 2 (2006), e43.
62. U. Lehmann, B. Hasemeier, M. Christgen, M. Muller, D. Romermann, F. Langer and H. Kreipe, Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer, J Pathol 214 (2008), 17-24.
63. A. Lembo, F. Di Cunto and P. Provero, Shortening of 3'UTRs correlates with poor prognosis in breast and lung cancer, PLoS One 7 (2012), e31129.
64. B. P. Lewis, I. H. Shih,M.W. Jones-Rhoades, D. P. Bartel and C. B. Burge, Prediction of mammalian microRNA targets, Cell 115 (2003), 787-798. (Pubitemid 38058492)
65. X. F. Li, P. J. Yan and Z. M. Shao, Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer, Oncogene 28 (2009), 3937-3948.
66. G. Lowe, R. Stike, M. Pollack, J. Bosley, P. O'Brien, A. Hake, G. Landis, N. Billings, P. Gordon, S. Manzella and T. Stover, Nursing blood specimen collection techniques and hemolysis rates in an emergency department: analysis of venipuncture versus intravenous catheter collection techniques, J Emerg Nurs 34 (2008), 26-32.
67. Q. Lu, J. Feng, Y. Yang, B. Nie, J. Bao, Z. Zhao, X. Feng, Y. Pei, L. Yuan, Z. Mei, R. Feng and Z. Jing, Treatment of type I endoleak after endovascular repair of infrarenal abdominal aortic aneurysm: Success of fibrin glue sac embolization, J Endovasc Ther 17 (2010), 687-693.
68. W. O. Lui, N. Pourmand, B. K. Patterson andA. Fire, Patterns of known and novel small RNAs in human cervical cancer, Cancer Res 67 (2007), 6031-6043. (Pubitemid 47037482)
69. L. Ma, F. Reinhardt, E. Pan, J. Soutschek, B. Bhat, E. G. Marcusson, J. Teruya-Feldstein, G. W. Bell and R. A. Weinberg, Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model, Nat Biotechnol 28 (2010), 341-347.
70. L. Ma, J. Teruya-Feldstein and R. A. Weinberg, Tumour invasion and metastasis initiated by microRNA-10b in breast cancer, Nature 449 (2007), 682-688. (Pubitemid 47552092)
71. T. Maciag, T. Mehlman, R. Friesel and A. B. Schreiber, Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain, Science 225 (1984), 932-935. (Pubitemid 14064174)
72. P. C. Maisonpierre, C. Suri, P. F. Jones, S. Bartunkova, S. J. Wiegand, C. Radziejewski, D. Compton, J. McClain, T. H. Aldrich, N. Papadopoulos, T. J.Daly, S. Davis, T. N. Sato and G. D. Yancopoulos, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis, Science 277 (1997), 55-60. (Pubitemid 27450643)
73. C. Mayr and D. P. Bartel, Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells, Cell 138 (2009), 673-684.
74. F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S. T. Jacob and T. Patel, MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer, Gastroenterology 133 (2007), 647-658. (Pubitemid 47187346)
75. A. Mitra, R. A. Fillmore, B. J. Metge, M. Rajesh, Y. Xi, J. King, J. Ju, L. Pannell, L. A. Shevde and R. S. Samant, Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer, Breast Cancer Res 10 (2008), R22.
76. A. Mitra, J. W. Rostas, D. L. Dyess, L. A. Shevde and R. S. Samant, Micro-RNA-632 downregulates DNAJB6 in breast cancer, Lab Invest 92 (2012), 1310-1317.
77. M. Moes, A. Le Bechec, I. Crespo, C. Laurini, A. Halavatyi, G. Vetter, A. Del Sol and E. Friederich, A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition, PLoS One 7 (2012), e35440.
78. D. X. Nguyen, P. D. Bos and J. Massague, Metastasis: From dissemination to organ-specific colonization, Nat Rev Cancer 9 (2009), 274-284.
79. D. O'Carroll and A. Schaefer, General Principals of miRNA Biogenesis and Regulation in the Brain, Neuropsychopharmacology 38 (2013), 39-54.
80. J. N. Painter, C. A. Anderson, D. R. Nyholt, S. Macgregor, J. Lin, S. H. Lee, A. Lambert, Z. Z. Zhao, F. Roseman, Q. Guo, S. D. Gordon, L. Wallace, A. K. Henders, P. M. Visscher, P. Kraft, N. G. Martin, A. P. Morris, S. A. Treloar, S. H. Kennedy, S. A. Missmer, G. W. Montgomery and K. T. Zondervan, Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis, Nat Genet 43 (2011), 51-54.
81. S. M. Park, A. B. Gaur, E. Lengyel and M. E. Peter, ThemiR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2, Genes Dev 22 (2008), 894-907. (Pubitemid 351482843)
82. A. Pettersson, J. A. Nagy, L. F. Brown, C. Sundberg, E. Morgan, S. Jungles, R. Carter, J. E. Krieger, E. J. Manseau, V. S. Harvey, I. A. Eckelhoefer, D. Feng, A. M. Dvorak, R. C. Mulligan and H. F. Dvorak, Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor, Lab Invest 80 (2000), 99-115. (Pubitemid 30067385)
83. K. J. Png, N. Halberg, M. Yoshida and S. F. Tavazoie, A microRNA regulon thatmediates endothelial recruitment and metastasis by cancer cells, Nature 481 (2011), 190-194.
84. M. Pongsavee, V. Yamkamon, S. Dakeng, O. c. P, D. R. Smith, G. F. Saunders and P. Patmasiriwat, The BRCA1 3'-UTR: 5711+421T/T 5711+1286T/T genotype is a possible breast and ovarian cancer risk factor, Genet Test Mol Biomarkers 13 (2009), 307-317.
85. H. Rajabi, C. Jin, R. Ahmad, C. McClary, M. D. Joshi and D. Kufe, Mucin 1 Oncoprotein expression is suppressed by the mir-125b oncomir, Genes Cancer 1 (2010), 62-68.
86. S. D. Reddy, K. Ohshiro, S. K. Rayala and R. Kumar, MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions, Cancer Res 68 (2008), 8195-8200.
87. B. J. Reinhart, F. J. Slack, M. Basson, A. E. Pasquinelli, J. C. Bettinger, A. E. Rougvie, H. R. Horvitz and G. Ruvkun, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans, Nature 403 (2000), 901-906. (Pubitemid 30130993)
88. S. D. Selcuklu, M. T. Donoghue, K. Rehmet, M. de Souza Gomes, A. Fort, P. Kovvuru, M. K. Muniyappa, M. J. Kerin, A. J. Enright and C. Spillane, MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells, J Biol Chem 287 (2012), 29516-29528.
89. X. B. Shi, L. Xue, J. Yang, A. H. Ma, J. Zhao, M. Xu, C. G. Tepper, C. P. Evans, H. J. Kung and R. W. deVere White, An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells, Proc Natl Acad Sci USA 104 (2007), 19983-19988.
90. Y. Shimono, M. Zabala, R. W. Cho, N. Lobo, P. Dalerba, D. Qian, M. Diehn, H. Liu, S. P. Panula, E. Chiao, F. M. Dirbas, G. Somlo, R. A. Pera, K. Lao and M. F. Clarke, Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells, Cell 138 (2009), 592-603.
91. Y. Shing, J. Folkman, R. Sullivan, C. Butterfield, J. Murray and M. Klagsbrun, Heparin affinity: purification of a tumorderived capillary endothelial cell growth factor, Science 223 (1984), 1296-1299. (Pubitemid 14163183)
92. F. Sun, H. Fu, Q. Liu, Y. Tie, J. Zhu, R. Xing, Z. Sun and X. Zheng, Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest, FEBS Lett 582 (2008), 1564-1568.
93. F. Tang, R. Zhang, Y. He, M. Zou, L. Guo and T. Xi, MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells, PLoS One 7 (2012), e35435.
94. S. F. Tavazoie, C. Alarcon, T. Oskarsson, D. Padua, Q.Wang, P. D. Bos,W. L. Gerald and J.Massague, Endogenous human microRNAs that suppress breast cancer metastasis, Nature 451 (2008), 147-152.
95. J. P. Thiery and J. P. Sleeman, Complex networks orchestrate epithelial-mesenchymal transitions, Nat RevMol Cell Biol 7 (2006), 131-142. (Pubitemid 43278296)
96. B. Tian, J. Hu, H. Zhang and C. S. Lutz, A large-scale analysis of mRNA polyadenylation of human and mouse genes, Nucleic Acids Res 33 (2005), 201-212. (Pubitemid 40276942)
97. V. P. Tryndyak, F. A. Beland and I. P. Pogribny, Ecadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells, Int J Cancer 126 (2010), 2575-2583.
98. J. Tsang, J. Zhu and A. van Oudenaarden, MicroRNAmediated feedback and feedforward loops are recurrent network motifs in mammals, Mol Cell 26 (2007), 753-767. (Pubitemid 46856248)
99. S. Valastyan, F. Reinhardt, N. Benaich, D. Calogrias, A. M. Szasz, Z. C. Wang, J. E. Brock, A. L. Richardson and R. A. Weinberg, A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis, Cell 137 (2009), 1032-1046.
100. K. Vleminckx, L. Vakaet, Jr., M. Mareel, W. Fiers and F. van Roy, Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role, Cell 66 (1991), 107-119. (Pubitemid 121001351)
101. S. Volinia, G. A. Calin, C. G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R. L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C. C. Harris and C. M. Croce, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc Natl Acad Sci USA 103 (2006), 2257-2261. (Pubitemid 43271657)
102. S.Wang, A. B. Aurora, B. A. Johnson, X. Qi, J.McAnally, J. A. Hill, J. A. Richardson, R. Bassel-Duby and E. N. Olson, The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis, Dev Cell 15 (2008), 261-271.
103. N. S. Wickramasinghe, T. T. Manavalan, S. M. Dougherty, K. A. Riggs, Y. Li and C. M. Klinge, Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells, Nucleic Acids Res 37 (2009), 2584-2595.
104. B. Wightman, I. Ha and G. Ruvkun, Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans, Cell 75 (1993), 855-862. (Pubitemid 24014543)
105. J.Winter, S. Jung, S. Keller, R. I. Gregory and S. Diederichs, Many roads to maturity: microRNA biogenesis pathways and their regulation, Nat Cell Biol 11 (2009), 228-234.
106. C. Y.Wu, Y. P. Tsai, M. Z.Wu, S. C. Teng and K. J.Wu, Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition, Trends Genet 28 (2012), 454-463.
107. Q.Wu, C.Wang, Z. Lu, L. Guo and Q. Ge, Analysis of serum genome-wide microRNAs for breast cancer detection, Clin Chim Acta 413 (2012), 1058-1065.
108. H. F. Xia, T. Z. He, C. M. Liu, Y. Cui, P. P. Song, X. H. Jin and X. Ma,MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf, Cell Physiol Biochem 23 (2009), 347-358.
109. M. Yamakuchi, M. Ferlito and C. J. Lowenstein, miR-34a repression of SIRT1 regulates apoptosis, Proc Natl Acad Sci USA 105 (2008), 13421-13426.
110. J. Yang and R. A.Weinberg, Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis, Dev Cell 14 (2008), 818-829. (Pubitemid 351757205)
111. Y. Zhang, L. X. Yan, Q. N. Wu, Z. M. Du, J. Chen, D. Z. Liao, M. Y. Huang, J. H. Hou, Q. L. Wu, M. S. Zeng, W. L. Huang, Y. X. Zeng and J. Y. Shao, miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer, Cancer Res 71 (2011), 3552-3562.
112. W. Zhu, W. Qin, U. Atasoy and E. R. Sauter, Circulating microRNAs in breast cancer and healthy subjects, BMC Res Notes 2 (2009), 89.
113. G. Zhuang, X. Wu, Z. Jiang, I. Kasman, J. Yao, Y. Guan, J. Oeh, Z. Modrusan, C. Bais, D. Sampath and N. Ferrara, Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway, EMBO J 31 (2012), 3513-3523.